The latest

Specialty Drugs: How Can Your Company Control These Steep Costs?

The headlines are scary: The prices of specialty drugs are projected to continue their unrelenting rise for the foreseeable…

Health Care Industry Evolution and Trends: Reflections From an Insurance Veteran, Part II

In part two of our interview, Ken Goulet, recently retired president of commercial business for Anthem Inc., discusses…

Health Care Industry Evolution and Trends: Reflections From an Insurance Veteran, Part I

Few have seen so much up-close change in the health care industry as Ken Goulet, recently retired president of commercial…